Chemical Structure : RMC-113
货号: PC-22226Not For Human Use, Lab Use Only.
RMC-113 a potent small molecule dual inhibitor of lipid kinases PIP4K2C and PIKfyve with binding Kd of 370 nM and 46 nM respectively, potently suppresses the replication of multiple RNA viruses including SARS-CoV-2.
大包装,大折扣!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
RMC-113 a potent small molecule dual inhibitor of lipid kinases PIP4K2C and PIKfyve with binding Kd of 370 nM and 46 nM respectively, potently suppresses the replication of multiple RNA viruses including SARS-CoV-2.
RMC-113 suppresses the enzymatic activity of PIKfyve (IC50=8 nM).
RMC-113 shows IC50 of 392 nM and 299.8 nM for PIP4K2C and PIKfyve in cell-based target engagement analysis via live-cell NanoBRET assays.
RMC-113 displays no activity against PIP4K2A and PIP4K2B, and low or no affinity for other kinases and overall excellent selectivity against 335 kinase panel.
RMC-113 dose dependently inhibits replication of WT and SARS-CoV-2 expressing Nluc-reporter (rSARS CoV-2/Nluc (USA-WA1/2020 strain)) in human lung epithelial (Calu-3) cells, as measured via plaque (EC50=0.25 μM) and luciferase (EC50=1.45 μM) assays, respectively.
RMC-113 also suppresses replication-restricted pseudovirus bearing SARS CoV-2 spike (S) protein (rVSV-SARS-CoV-2-S) in Vero cells (EC50=1.8 μM).
RMC-113 dose-dependently suppressed SARS-CoV-2 replication measured in ALO culture supernatants by plaque assays (EC50=0.15 μM) and nucleocapsid (N) transcript expression measured in ALO lysates by RT-qPCR (EC50=0.35 μM), and CC50 >10 μM.
分子量 | 373.43 | |
分子式 | C21H15N3O2S | |
外观性状 | Solid | |
储存条件 |
|
|
Solubility |
10 mM in DMSO |
1. Marwah Karim, et al. bioRxiv. 2024 Apr 17:2024.04.15.589676.
备案号:沪ICP备16042516号-1 Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright